Non-stick nano-coating could solve delivery challenges in the brain
The answer to the brain drug delivery riddle could soon be solved thanks to new nanoparticles designed by researchers at John Hopkins University.
Archives for September 11, 2012
Qualitest pulls out-of-spec pain drug
Generic drugmaker Qualitest Pharmaceuticals has pulled a lot of hydrocodone tablets over concerns they may be out of spec.
Jamaica issues $3bn worth of drug supply contracts
Lasco, Medimpax and GSK are among those to receive manufacturing and supply deals under the J$3.3bn ($37m) worth of contracts issued by the Jamaican Government.
API production will boost contract pharma manufacturing biz
Active pharmaceutical ingredient production will be the driving factor behind a predicted boom in the pharmaceutical contract manufacturing market, according to Visiongain.
UPDATE
Health Canada launches risk-based inspection classification system
Since the publication of this article, in-PharmaTechnologist.com has been in touch with Health Canada to find out that the "updates" to the guidance document were actually to the font, not to the regulations. Health Canada launched no disclaimer with the...
Wuxi's JV with MedImmune will increase costs, says analyst
Wuxi Apptec's new risk-sharing JV with MedImmune is likely to have negative impact on short-term margins, says analyst.
EC GMP revisions have implications for CMOs
Changes to European GMP guidelines designed to align them with ICH Q10 have significant implications for CMO contracts.
Asthma sufferers could ditch daily inhalers, says UTMB
Asthma sufferers could soon ditch their daily steroid inhalers after scientists found it unnecessary.
EC revises GMP guidelines to align them with ICH Q10
The European Commission (EC) has made changes to its GMP guidelines in order to align them more closely with the pharmaceutical quality system described in ICH Q10.